"Ovarian Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Descriptor ID |
D010051
|
MeSH Number(s) |
C04.588.322.455 C13.351.500.056.630.705 C13.351.937.418.685 C19.344.410 C19.391.630.705
|
Concept/Terms |
Ovarian Neoplasms- Ovarian Neoplasms
- Neoplasm, Ovarian
- Ovarian Neoplasm
- Ovary Neoplasms
- Neoplasm, Ovary
- Neoplasms, Ovary
- Ovary Neoplasm
- Neoplasms, Ovarian
Ovary Cancer- Ovary Cancer
- Cancer, Ovary
- Cancers, Ovary
- Ovary Cancers
- Ovarian Cancer
- Cancer, Ovarian
- Cancers, Ovarian
- Ovarian Cancers
- Cancer of Ovary
- Cancer of the Ovary
|
Below are MeSH descriptors whose meaning is more general than "Ovarian Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Ovarian Neoplasms".
This graph shows the total number of publications written about "Ovarian Neoplasms" by people in this website by year, and whether "Ovarian Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 2 | 0 | 2 |
2005 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2008 | 2 | 0 | 2 |
2010 | 1 | 0 | 1 |
2011 | 2 | 1 | 3 |
2012 | 1 | 0 | 1 |
2013 | 3 | 0 | 3 |
2014 | 1 | 0 | 1 |
2015 | 3 | 0 | 3 |
2016 | 6 | 0 | 6 |
2017 | 77 | 10 | 87 |
2018 | 52 | 5 | 57 |
2019 | 34 | 1 | 35 |
2020 | 5 | 0 | 5 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ovarian Neoplasms" by people in Profiles.
-
Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases. Biomolecules. 2021 05 28; 11(6).
-
Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic. Int J Gynecol Cancer. 2021 06; 31(6):883-887.
-
Estrogen and COVID-19: friend or foe? Ann Oncol. 2021 07; 32(7):933-934.
-
Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. J Ovarian Res. 2021 Feb 25; 14(1):39.
-
Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China. J Ovarian Res. 2021 Feb 18; 14(1):35.
-
Experiences of women with ovarian cancer during the COVID-19 pandemic: Examining intolerance of uncertainty and fear of COVID-19 in relation to psychological distress. J Psychosoc Oncol. 2021; 39(3):399-415.
-
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied? J Ovarian Res. 2021 Feb 08; 14(1):28.
-
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy. Ann Oncol. 2021 05; 32(5):676-677.
-
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals. Expert Rev Mol Diagn. 2021 01; 21(1):101-107.
-
BRCA testing delay during the COVID-19 pandemic: How to act? Mol Biol Rep. 2021 Jan; 48(1):983-987.